Naung Latt Htun: High Clinical Suspicion in Acquired Hemophilia A is Essential
Naung Latt Htun, Internal Medicine Doctor at Ministry of Health Brunei Darussalam, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share that our latest case report has been published in Cureus Journal of Medical Science!
Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies
In this paper, we present two rare and clinically challenging cases of AHA – an uncommon but potentially life-threatening autoimmune bleeding disorder caused by factor VIII inhibitors.
Key highlights:
- AHA can present with unexplained bleeding and isolated prolonged aPTT
- Underlying causes can be diverse – including malignancy, autoimmune conditions, and infections
- Coexistence with antiphospholipid antibodies creates a complex paradox of bleeding vs thrombosis
- Early recognition and a dual management approach (bleeding control plus inhibitor eradication) are critical
These cases emphasize the importance of maintaining a high index of suspicion when evaluating unexplained bleeding, especially in patients with comorbid conditions.
Proud to have worked with an excellent team on this publication!”
Title: Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies
Authors: Naung Latt Htun, Hsan Theingi Win, Mohammad Abdullah, Hnin Kay Khine Oo, Dilip Thottacherry
Read the Full Article on Cureus Journal of Medical Science
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 15, 2026, 19:41Looking Beyond Platelet Counts to Quality of Life in ITP – American Society of Hematology
-
Oct 15, 2026, 19:32Markus Gregorio Barbosa: Hepatic VPS35 and Cholesterol Homeostasis
-
Oct 15, 2026, 19:18Emerging Novel Therapies for Hereditary Hemorrhagic Telangiectasia – The Lancet Haematology
-
Oct 15, 2026, 19:04Umberto Pensato: EVT Treatment Effects Across Perfusion Profiles in MeVO Stroke
-
Oct 15, 2026, 18:26Chanakya Nayudu: Presenting My Research at ISTH Congress 2026 in Paris
-
Oct 15, 2026, 18:09Maha Othman: Students Lead World Thrombosis Day 2026 Awareness Events
-
Oct 15, 2026, 17:52Jill de Mol։ Rapamycin Modulates Immune Responses in Aged Atherosclerosis
-
Oct 15, 2026, 17:41Victor Aboyans։ Think About Lipids in VTE
-
Oct 15, 2026, 17:08Babu Mia։ Targeting PPM1D to Eliminate Malignant Stem Cells in Myeloproliferative Neoplasms